Co-reporter:Xueyin Wang, Karen J. Goodrich, Anne R. Gooding, Haroon Naeem, ... Chen Davidovich
Molecular Cell 2017 Volume 65, Issue 6(Volume 65, Issue 6) pp:
Publication Date(Web):16 March 2017
DOI:10.1016/j.molcel.2017.02.003
•PRC2 binds to an RNA motif composed of short repeats of consecutive guanines•The natural abundance of this motif explains promiscuous RNA binding by PRC2•PRC2 has a high affinity for G-quadruplex RNA and little affinity for duplex RNA•Enrichment of the motif at PRC2 target genes provides a means for regulation in cisPolycomb repressive complex 2 (PRC2) is a histone methyltransferase that trimethylates H3K27, a mark of repressed chromatin. Mammalian PRC2 binds RNA promiscuously, with thousands of target transcripts in vivo. But what does PRC2 recognize in these RNAs? Here we show that purified human PRC2 recognizes G > C,U ≫ A in single-stranded RNA and has a high affinity for folded guanine quadruplex (G4) structures but little binding to duplex RNAs. Importantly, G-tract motifs are significantly enriched among PRC2-binding transcripts in vivo. DNA sequences coding for PRC2-binding RNA motifs are enriched at PRC2-binding sites on chromatin and H3K27me3-modified nucleosomes. Collectively, the abundance of PRC2-binding RNA motifs rationalizes the promiscuous RNA binding of PRC2, and their enrichment at Polycomb target genes provides a means for RNA-mediated regulation.Download high-res image (219KB)Download full-size image
Co-reporter:Scott B. Cohen;Linghe Xi;Dan Theodorescu;Natasha M. Powell;Arthur J. Zaug;Sumit Borah;Garrett M. Dancik;James C. Costello
Science 2015 Volume 347(Issue 6225) pp:1006-1010
Publication Date(Web):27 Feb 2015
DOI:10.1126/science.1260200
The downstream effects of false promotion
Special DNA sequences at the ends of chromosomes, called telomeres, are replenished by a dedicated enzyme called telomerase. A subset of human tumors harbors mutations in the promoter region of the TERT gene, which codes for a subunit of telomerase. Borah et al. explored the downstream effects of TERT promoter mutations in cells derived from urothelial (urinary tract) cancers. The mutations were associated with aberrantly high levels of TERT mRNA, TERT protein and telomerase activity, and longer telomeres. A small study of clinical samples suggested that high levels of TERT mRNA may be a marker of more aggressive urothelial cancers.
Science, this issue p. 1006
Co-reporter:Jayakrishnan Nandakumar
&
Thomas R. Cech
Nature Reviews Molecular Cell Biology 2013 14(2) pp:69
Publication Date(Web):2013-01-09
DOI:10.1038/nrm3505
Telomeres, the ends of linear eukaryotic chromosomes, are characterized by the presence of multiple repeats of a short DNA sequence. This telomeric DNA is protected from illicit repair by telomere-associated proteins, which in mammals form the shelterin complex. Replicative polymerases are unable to synthesize DNA at the extreme ends of chromosomes, but in unicellular eukaryotes such as yeast and in mammalian germ cells and stem cells, telomere length is maintained by a ribonucleoprotein enzyme known as telomerase. Recent work has provided insights into the mechanisms of telomerase recruitment to telomeres, highlighting the contribution of telomere-associated proteins, including TPP1 in humans, Ccq1 in Schizosaccharomyces pombe and Cdc13 and Ku70–Ku80 in Saccharomyces cerevisiae.
Co-reporter: Thomas R. Cech
Angewandte Chemie 2013 Volume 125( Issue 1) pp:78-82
Publication Date(Web):
DOI:10.1002/ange.201205427
Co-reporter: Thomas R. Cech
Angewandte Chemie International Edition 2013 Volume 52( Issue 1) pp:75-78
Publication Date(Web):
DOI:10.1002/anie.201205427
Co-reporter:Jayakrishnan Nandakumar;Elaine R. Podell
PNAS 2010 Volume 107 (Issue 2 ) pp:651-656
Publication Date(Web):2010-01-12
DOI:10.1073/pnas.0911099107
The POT1-TPP1 heterodimer, the major telomere-specific single-stranded DNA-binding protein in mammalian cells, protects chromosome
ends and contributes to the regulation of telomerase. The recent discovery of telomeric RNA raises the question of how POT1
faithfully binds telomeric ssDNA and avoids illicit RNA binding that could result in its depletion from telomeres. Here we
show through binding studies that a single deoxythymidine in a telomeric repeat dictates the DNA versus RNA discrimination
by human POT1 and mouse POT1A. We solve the crystal structure of hPOT1 bound to DNA with a ribouridine in lieu of the critical
deoxythymidine and show that this substitution results in burying the 2′-hydroxyl group in a hydrophobic region (Phe62) of POT1 in addition to eliminating favorable hydrogen-bonding interactions
at the POT1–nucleic acid interface. At amino acid 62, Phe discriminates against RNA binding and Tyr allows RNA binding. We
further show that TPP1 greatly augments POT1’s discrimination against RNA.
Co-reporter:Feng Qiao;Karen J. Goodrich
PNAS 2010 Volume 107 (Issue 11 ) pp:4914-4918
Publication Date(Web):2010-03-16
DOI:10.1073/pnas.0909366107
Telomerase is a ribonucleoprotein complex consisting of a protein reverse transcriptase (TERT) and an RNA subunit (TR). Telomerase
normally adds telomeric DNA repeats to chromosome ends. Here, we engineer human and Tetrahymena cis-telomerase RNAs, each having a DNA primer covalently linked to its 3′ end. We find that cis-telomerase synthesizes DNA
with increased repeat addition processivity (RAP) but does not completely rescue the RAP defect of the L14A mutant of Tetrahymena TERT. This supports the conclusion that L14 has a function beyond binding the DNA primer and preventing dissociation during
multiple rounds of repeat addition. By comparing cis-telomerases with various linker lengths, we find that a 5 nt linker gives
near-optimal activity, indicating that the distance between the 3′ end of the telomerase RNA pseudoknot region and the 5′
end of the DNA primer is ∼33 Å. Even a 2 nt linker (∼14 Å) gives some activity, indicating a high degree of conformational flexibility in this ribonucleoprotein complex. More generally,
the cis system will allow structure-function relationships of each RNA molecule to be read directly through the reaction that
it performs on itself.
Co-reporter:Elaine R. Podell;Arthur J. Zaug
PNAS 2005 Volume 102 (Issue 31 ) pp:10864-10869
Publication Date(Web):2005-08-02
DOI:10.1073/pnas.0504744102
The POT1 (protection of telomeres 1) protein binds the ssDNA overhangs at the ends of chromosomes in diverse eukaryotes. POT1
is essential for chromosome end-protection, as best demonstrated in fission yeast. In human cells, hPOT1 is also involved
in telomere-length regulation. We now show that telomeric oligonucleotides, such as d[GGG(TTAGGG)3], which form intramolecular G-quadruplexes through Hoogsteen base-pairing, serve as only marginal primers for extension by
recombinant human telomerase; telomerase stalls after every nucleotide addition. Addition of hPOT1 to the reaction restores
the normal processive elongation pattern seen with primers that cannot form G-quadruplexes. hPOT1 does not act catalytically
but, instead, forms a stoichiometric complex with the DNA, freeing its 3′ tail. An antisense oligonucleotide, which base-pairs
near the 5′ end of the telomeric sequence, leaving a telomerase-extendible 3′ tail, duplicates the effect of hPOT1 on activation
of G-quadruplex primers. Thus, hPOT1 may function simply by trapping the unfolded forms of these telomeric primers in an equilibrium
population. We propose an additional role for hPOT1 in telomere maintenance: disrupting G-quadruplex structures in telomeric
DNA, thereby allowing proper elongation by telomerase.
Co-reporter:
Nature Structural and Molecular Biology 2004 11(12) pp:1223-1229
Publication Date(Web):21 November 2004
DOI:10.1038/nsmb867
The POT1 (protection of telomeres 1) protein binds the single-stranded overhang at the ends of chromosomes in diverse eukaryotes. It is essential for chromosome end-protection in the fission yeast Schizosaccharomyces pombe, and it is involved in regulation of telomere length in human cells. Here, we report the crystal structure at a resolution of 1.73 Å of the N-terminal half of human POT1 (hPOT1) protein bound to a telomeric single-stranded DNA (ssDNA) decamer, TTAGGGTTAG, the minimum tight-binding sequence indicated by in vitro binding assays. The structure reveals that hPOT1 contains two oligonucleotide/ oligosaccharide-binding (OB) folds; the N-terminal OB fold binds the first six nucleotides, resembling the structure of the S. pombe Pot1pN−ssDNA complex, whereas the second OB fold binds and protects the 3' end of the ssDNA. These results provide an atomic-resolution model for chromosome end-capping.
Co-reporter:David C. Zappulla;
Proceedings of the National Academy of Sciences 2004 101(27) pp:10024-10029
Publication Date(Web):June 28, 2004
DOI:10.1073/pnas.0403641101
In the yeast Saccharomyces cerevisiae, distinct regions of the 1.2-kb telomerase RNA (TLC1) bind to the catalytic subunit Est2p and to accessory proteins. In particular,
a bulged stem structure binds the essential regulatory subunit Est1p. We now show that the Est1p-binding domain of the RNA
can be moved to three distant locations with retention of telomerase function in vivo. We present the Est1p relocation experiment in the context of a working model for the secondary structure of the entire TLC1
RNA, based on thermodynamic considerations and comparative analysis of sequences from four species. The model for TLC1 has
three long quasihelical arms that bind the Ku, Est1p, and Sm proteins. These arms emanate from a central catalytic core that
contains the template and Est2p-binding region. Deletion mutagenesis provides evidence that the Sm arm exists in vivo and can be shortened by 42 predicted base pairs with retention of function; therefore, precise positioning of Sm proteins,
like Est1p, is not required within telomerase. In the best-studied ribonucleoprotein enzyme, the ribosome, the RNAs have specific
three-dimensional structures that orient the functional elements. In the case of yeast telomerase, we propose that the RNA
serves a very different function, providing a flexible tether for the protein subunits.
Co-reporter:Ming Lei,
Elaine R. Podell,
Peter Baumann
and
Thomas R. Cech
Nature 2003 426(6963) pp:198
Publication Date(Web):
DOI:10.1038/nature02092
Co-reporter:Christian H. Haering;Peter Baumann;Toru M. Nakamura
PNAS 2000 Volume 97 (Issue 12 ) pp:6367-6372
Publication Date(Web):2000-06-06
DOI:10.1073/pnas.130187397
The chromosome end-replicating enzyme telomerase is composed of a
template-containing RNA subunit, a reverse transcriptase (TERT), and
additional proteins. The importance of conserved amino acid residues in
Trt1p, the TERT of Schizosaccharomyces pombe, was
tested. Mutation to alanine of the proposed catalytic aspartates in
reverse transcriptase motifs A and C and of conserved amino acids in
motifs 1 and B′ resulted in defective growth, progressive loss of
telomeric DNA, and loss of detectable telomerase enzymatic activity
in vitro. Mutation of the phenylalanine (F) in the
conserved FYxTE of telomerase-specific motif T had no phenotype
in vivo or in vitro whereas mutation of a
conserved amino acid in RT motif 2 had an intermediate effect. In
addition to identifying single amino acids of TERT required for
telomere maintenance in the fission yeast, this work provides useful
tools for S. pombe telomerase research: a functional
epitope-tagged version of Trt1p that allows detection of the protein
even in crude cellular extracts, and a convenient and robust in
vitro enzymatic activity assay based on immunopurification of
telomerase.
Co-reporter:Thomas R. Cech Dr.
Angewandte Chemie International Edition 2000 Volume 39(Issue 1) pp:
Publication Date(Web):12 JAN 2000
DOI:10.1002/(SICI)1521-3773(20000103)39:1<34::AID-ANIE34>3.0.CO;2-N
Telomerase, the enzyme that replicates the ends of linear chromosomes, is implicated in cellular aging and in cancer. The molecular components that form the catalytic core of this ribonucleoprotein enzyme (a section of the active site with bound substrates is depicted) have recently been identified in multiple organisms, including humans. The stage is now set for chemists to develop telomerase inhibitors, which hold promise as cancer chemotherapeutic agents.
Co-reporter:Thomas R. Cech Dr.
Angewandte Chemie 2000 Volume 112(Issue 1) pp:
Publication Date(Web):12 JAN 2000
DOI:10.1002/(SICI)1521-3757(20000103)112:1<34::AID-ANGE34>3.0.CO;2-2
An zellulären Alterungsprozessen und Krebs ist die Telomerase beteiligt, das Enzym, das die Enden linearer Chromosomen repliziert. Die molekularen Komponenten, die den katalytisch wirksamen Kern dieses Ribonucleoprotein-Enzyms bilden (gezeigt ist ein Ausschnitt des aktiven Zentrums mit gebundenen Substraten), wurden kürzlich in einer Reihe von Organismen einschließlich des Menschen identifiziert. Damit sind für Chemiker die Voraussetzungen für die Entwicklung von Telomeraseinhibitoren geschaffen, die als Chemotherapeutika zur Behandlung von Krebs eingesetzt werden könnten.
Co-reporter:Anita G. Seto,
Arthur J. Zaug,
Suzanne G. Sobel,
Sandra L. Wolin
and
Thomas R. Cech
Nature 1999 401(6749) pp:177
Publication Date(Web):
DOI:10.1038/43694
Activation of the chromosome end-replicating enzyme telomerase can greatly extend the lifespan of normal human cells1 and is associated with most human cancers2. In all eukaryotes examined, telomerase has an RNA subunit3, a conserved reverse transcriptase subunit4 and additional proteins5, 6, but little is known about the assembly of these components. Here we show that the Saccharomyces cerevisiae telomerase RNA7 has a 5′-2,2,7-trimethylguanosine (TMG) cap and a binding site for the Sm proteins, both hallmarks of small nuclear ribonucleoprotein particles (snRNPs) that are involved in nuclear messenger RNA splicing8, 9. Immunoprecipitation of telomerase from yeast extracts shows that Sm proteins are assembled on the RNA and that most or all of the telomerase activity is associated with the Sm-containing complex. These data support a model in which telomerase RNA is transcribed by RNA polymerase II (ref. 10) and 7-methylguanosine-capped, binds the seven Sm proteins, becomes TMG-capped and picks up the other protein subunits. We conclude that the functions of snRNPs assembled by this pathway are not restricted to RNA processing, but also include chromosome telomere replication.
Co-reporter:Lara B. Weinstein;B. C. N. M. Jones;Richard Cosstick
Nature 1997 388(6644) pp:805-808
Publication Date(Web):1997-08-21
DOI:10.1038/42076
Although only a subset of protein enzymes depend on the presence of a metal ion for their catalytic function, all naturally occurring RNA enzymes require metal ions to stabilize theirstructure and for catalytic competence1. In the self-splicing group I intron from Tetrahymena thermophila2, several divalent metals can serve structural roles, but only Mg2+ and Mn2+ promote splice-site cleavage and exon ligation3,4. A study of a ribozyme reaction analogous to 5'-splice-site cleavage by guanosine uncovered the first metal ion with a definitive role in catalysis. Substitution of the 3'-oxygen of the leaving group with sulphur resulted in a metal-specificity switch, indicating an interaction between the leaving group and the metal ion5. Here we use 3'-(thioinosylyl)-(3' 5')-uridine6, IspU, as a substrate in a reaction that emulates exon ligation. Activity requires the addition of a thiophilic metal ion (Cd2+ or Mn2+), providing evidence for stabilization of the leaving group by a metal ion in that step of splicing. Based on the principle of microscopic reversibility, this metal ion activates the nucleophilic 3'-hydroxyl of guanosine in the first step of splicing, supporting the model of a two-metal-ion active site7.
Co-reporter:Biliang Zhang
and
Thomas R. Cech
Nature 1997 390(6655) pp:96
Publication Date(Web):
DOI:10.1038/36375
An attractive solution to the problem of the origin of protein synthesis
in an evolving 'RNA world' involves catalysis by nucleic acid
without assistance from proteins1,2. Indeed, even
the modern ribosome has been considered to be fundamentally an RNA machine3, and the large ribosomal subunit can carry out peptidyl transfer
in the absence of most of its protein subunits4. Successive
cycles of in vitro selection and amplification5, 6, 7
have been used to find RNAs that perform many biochemical reactions8, 9, 10, 11, 12, 13, 14, 15, 16,
including transfer of an RNA-linked amino acid to their own 5'-amino-modified
terminus15. Here we demonstrate the in vitro selection
of ribozymes (196 nucleotides) that perform the same peptidyl transferase
reaction as the ribosome: that is, they can join amino acids by a peptide
bond. Like ribosome substrates, one amino acid (N-blocked methionine) is esterified
to the 3'(2')-O of adenosine, whereas the acceptor amino acid
(phenylalanine) has a free amino group. Our best characterized ribozyme recognizes
the amino-acid ester substrate by binding its adenosine moiety, and is therefore
capable of utilizing Leu- and Phe- as well as Met-derived substrates. Such
lack of specificity with respect to the amino acid is a feature necessary
for a generalized protein-synthesizing enzyme.
Co-reporter:Chen Davidovich, Xueyin Wang, Catherine Cifuentes-Rojas, Karen J. Goodrich, ... Thomas R. Cech
Molecular Cell (5 February 2015) Volume 57(Issue 3) pp:552-558
Publication Date(Web):5 February 2015
DOI:10.1016/j.molcel.2014.12.017
•Promiscuous and specific RNA-binding properties of PRC2 are not mutually exclusive•Human and mouse PRC2 bind RNA similarly in vitro, with RepA lncRNA being a good ligand•Controlling for RNA length is essential to assess PRC2 binding specificity in vitro•Previous evidence for a small hairpin motif for PRC2 in vivo is re-examinedPolycomb repressive complex-2 (PRC2) is a histone methyltransferase required for epigenetic silencing during development and cancer. Early works suggested binding specificity of PRC2 to certain long non-coding RNAs for recruitment to chromatin. More recent studies provided evidence both in favor and against this idea. Here, we bridge the two existing models of PRC2-RNA interaction. RepA RNA is a good binding partner for PRC2, while multiple non-relevant RNAs, including bacterial mRNAs, also bind PRC2; Kds depend to some extent on the experimental conditions. Human and mouse PRC2 have broadly similar RNA-binding properties in vitro. Examination of evidence supporting an existing model for site-specific recruitment of PRC2 by a well-defined RNA motif in cells reveals that results are PRC2 independent. We conclude that promiscuous and specific RNA-binding activities of PRC2 in vitro are not mutually exclusive, and that binding specificity in vivo remains to be demonstrated.Download high-res image (186KB)Download full-size image
Co-reporter:Andrew B. Dalby, Ctirad Hofr, Thomas R. Cech
Journal of Molecular Biology (27 March 2015) Volume 427(Issue 6) pp:1291-1303
Publication Date(Web):27 March 2015
DOI:10.1016/j.jmb.2015.01.008
•The TEL-patch on TPP1 promotes the translocation of human telomerase.•The TEL-patch of TPP1 reduces substrate dissociation from telomerase.•Telomerase interacts with TPP1 to preferentially bind and extend substrates.•Toward an in vitro assay for telomerase recruitment to telomeres.Telomere maintenance is a highly coordinated process, and its misregulation is linked to cancer and telomere-shortening syndromes. Recent studies have shown that the TEL-patch—a cluster of amino acids on the surface of the shelterin component TPP1—is necessary for the recruitment of telomerase to the telomere in human cells. However, there has been only basic biochemical analysis of the role of TPP1 in the telomerase recruitment process. Here we develop an in vitro assay to quantitatively measure the contribution of the TEL-patch to telomerase recruitment—binding and extension of the first telomeric repeat. We also demonstrate that the TEL-patch contributes to the translocation step of the telomerase reaction. Finally, our quantitative observations indicate that the TEL-patch stabilizes the association between telomerase and telomeric DNA substrates, providing a molecular explanation for its contributions to telomerase recruitment and action.Download high-res image (179KB)Download full-size image
Co-reporter:David B. McKay, Linghe Xi, Kristen K.B. Barthel, Thomas R. Cech
Journal of Molecular Biology (17 April 2014) Volume 426(Issue 8) pp:1766-1785
Publication Date(Web):17 April 2014
DOI:10.1016/j.jmb.2014.01.006
•Current model: SRAP modulates SRA RNA, a transcriptional regulator, by binding SRA.•SRAP–SRA binding experiments in vitro and in cells do not show specific binding.•Crystal structure of the C-terminal domain of SRAP shows that it is similar to PRP18.•siRNA knockdowns of SRA/SRAP show only a minor effect on transcription.•Data do not support the current model for SRAP activity; alternatives are discussed.In a widely accepted model, the steroid receptor RNA activator protein (SRA protein; SRAP) modulates the transcriptional regulatory activity of SRA RNA by binding a specific stem–loop of SRA. We first confirmed that SRAP is present in the nucleus as well as the cytoplasm of MCF-7 breast cancer cells, where it is expressed at the level of about 105 molecules per cell. However, our SRAP–RNA binding experiments, both in vitro with recombinant protein and in cultured cells with plasmid-expressed protein and RNA, did not reveal a specific interaction between SRAP and SRA. We determined the crystal structure of the carboxy-terminal domain of human SRAP and found that it does not have the postulated RRM (RNA recognition motif). The structure is a five-helix bundle that is distinct from known RNA-binding motifs and instead is similar to the carboxy-terminal domain of the yeast spliceosome protein PRP18, which stabilizes specific protein–protein interactions within a multisubunit mRNA splicing complex. SRA binding experiments with this domain gave negative results. Transcriptional regulation by SRA/SRAP was examined with siRNA knockdown. Effects on both specific estrogen-responsive genes and genes identified by RNA-seq as candidates for regulation were examined in MCF-7 cells. Only a small effect (~ 20% change) on one gene resulting from depletion of SRA/SRAP could be confirmed. We conclude that the current model for SRAP function must be reevaluated; we suggest that SRAP may function in a different context to stabilize specific intermolecular interactions in the nucleus.Download high-res image (90KB)Download full-size image
Co-reporter:Derek J. Taylor, Elaine R. Podell, Dylan J. Taatjes, Thomas R. Cech
Journal of Molecular Biology (1 July 2011) Volume 410(Issue 1) pp:10-17
Publication Date(Web):1 July 2011
DOI:10.1016/j.jmb.2011.04.049
Telomeres are nucleoprotein complexes that cap and protect the ends of linear chromosomes. In humans, telomeres end in 50–300 nt of G-rich single-stranded DNA (ssDNA) overhangs. Protection of telomeres 1 (POT1) binds with nanomolar affinity to the ssDNA overhangs and forms a dimer with another telomere-end binding protein called TPP1. Whereas most previous studies utilized telomeric oligonucleotides comprising single POT1–TPP1 binding sites, here, we examined 72- to 144-nt tracts of telomeric DNA containing 6–12 POT1–TPP1 binding sites. Using electrophoretic mobility gel shift assays, size-exclusion chromatography, and electron microscopy, we analyzed telomeric nucleoprotein complexes containing POT1 alone, POT1–TPP1, and a truncated version of POT1 (POT1-N) that maintains its DNA-binding domain. The results revealed that POT1-N and POT1–TPP1 can completely coat long telomeric ssDNA substrates. Furthermore, we show that ssDNA coated with human POT1–TPP1 heterodimers forms compact, potentially ordered structures.